➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt

Last Updated: January 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for CAM2038

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug CAM2038?

CAM2038 is an investigational drug.

There have been 10 clinical trials for CAM2038. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2020.

The most common disease conditions in clinical trials are Disease, Substance-Related Disorders, and Substance Withdrawal Syndrome. The leading clinical trial sponsors are Braeburn Pharmaceuticals, National Institute on Drug Abuse (NIDA), and Theresa Winhusen, PhD.

There are six hundred and nine US patents protecting this investigational drug and eight international patents.

Recent Clinical Trials for CAM2038
TitleSponsorPhase
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyNational Institute on Drug Abuse (NIDA)Phase 3
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyThe EMMES CorporationPhase 3
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyTheresa Winhusen, PhDPhase 3

See all CAM2038 clinical trials

Clinical Trial Summary for CAM2038

Top disease conditions for CAM2038
Top clinical trial sponsors for CAM2038

See all CAM2038 clinical trials

US Patents for CAM2038

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CAM2038   Start Trial Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA)   Start Trial
CAM2038   Start Trial Tactile sensing device for lumbar punctures TEXAS MEDICAL CENTER (Houston, TX)   Start Trial
CAM2038   Start Trial Methods and devices to reduce damaging effects of concussive or blast forces on a subject TBI INNOVATIONS, LLC (Richmond, IN) THORNHILL RESEARCH, INC. (Toronto, Ontario, CA)   Start Trial
CAM2038   Start Trial Pharmaceutical formulations GW Pharma Limited (Cambridge, GB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for CAM2038

Drugname Country Document Number Estimated Expiration Related US Patent
CAM2038 European Patent Office EP2981556 2033-04-02   Start Trial
CAM2038 World Intellectual Property Organization (WIPO) WO2014165513 2033-04-02   Start Trial
CAM2038 Australia AU2017260251 2036-05-03   Start Trial
CAM2038 Canada CA3022932 2036-05-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.